Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?

被引：5

作者：

Bowsher, Ronald R. ^{[1
]}

Devanarayan, Viswanath ^{[2
,3
]}

机构：

[1] B2S Life Sci Llc, 97 East Monroe St, Franklin, IN 46131 USA

[2] GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426 USA

[3] Univ Illinois, 1200 W Harrison St, Chicago, IL 60607 USA

来源：

AAPS JOURNAL | 2020年 / 22卷 / 06期

关键词：

COVID-19; cut point; diagnostics; immunogenicity; serology; statistics; HOST ANTIBODIES; RECOMMENDATIONS;

D O I：

10.1208/s12248-020-00510-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：5

共 23 条

[1]

Amanat F, 2020, NAT MED, V26, P1033

[2] Distinct Early Serological Signatures Track with SARS-CoV-2 Survival [J].

Atyeo, Caroline ;

Fischinger, Stephanie ;

Zohar, Tomer ;

Slein, Matthew D. ;

Burke, John ;

Loos, Carolin ;

McCulloch, Denise J. ;

Newman, Kira L. ;

Wolf, Caitlin ;

Yu, Jingyou ;

Shuey, Kiel ;

Feldman, Jared ;

Hauser, Blake Marie ;

Caradonna, Tim ;

Schmidt, Aaron G. ;

Suscovich, Todd J. ;

Linde, Caitlyn ;

Cai, Yongfei ;

Barouch, Dan ;

Ryan, Edward T. ;

Charles, Richelle C. ;

Lauffenburger, Douglas ;

Chu, Helen ;

Alter, Galit .

IMMUNITY, 2020, 53 (03) :524-+

[3] Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States [J].

Baughman, AL ;

Bisgard, KM ;

Edwards, KM ;

Guris, D ;

Decker, MD ;

Holland, K ;

Meade, BD ;

Lynn, F .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (06) :1045-1053

[4]

cdc, COVID Data Tracker

[5] Serodiagnostics for Severe Acute Respiratory Syndrome-Related Coronavirus 2 A Narrative Review [J].

Cheng, Matthew P. ;

Yansouni, Cedric P. ;

Basta, Nicole E. ;

Desjardins, Michael ;

Kanjilal, Sanjat ;

Paquette, Katryn ;

Caya, Chelsea ;

Semret, Makeda ;

Quach, Caroline ;

Libman, Michael ;

Mazzola, Laura ;

Sacks, Jilian A. ;

Dittrich, Sabine ;

Papenburg, Jesse .

ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) :450-+

[6] Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points [J].

Devanarayan, Viswanath ;

Smith, Wendell C. ;

Brunelle, Rocco L. ;

Seger, Mary E. ;

Krug, Kim ;

Bowsher, Ronald R. .

AAPS JOURNAL, 2017, 19 (05) :1487-1498

[7]

European Medicines Agency, 2017, EMEACHMPBMWP

[8]

Hicks J, 2020, medRxiv, DOI [10.1101/2020.06.22.20137695, 10.1101/2020.06.22.20137695, DOI 10.1101/2020.06.22.20137695, https://doi.org/10.1101/2020.06.22.20137695]

[9] Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products [J].

Koren, Eugen ;

Smith, Holly W. ;

Shores, Elizabeth ;

Shankar, Gopi ;

Finko-Kent, Deborah ;

Rup, Bonita ;

Barrett, Yu-Chen ;

Devanarayan, Viswanath ;

Gorovits, Boris ;

Gupta, Shalini ;

Parish, Thomas ;

Quarmby, Valerie ;

Moxness, Michael ;

Swanson, Steven J. ;

Taniguchi, Gary ;

Zuckerman, Linda A. ;

Stebbins, Christopher C. ;

Mire-Sluis, Anthony .

JOURNAL OF IMMUNOLOGICAL METHODS, 2008, 333 (1-2) :1-9

[10] The COVID-19 Serology Studies Workshop: Recommendations and Challenges [J].

Lerner, Andrea M. ;

Eisinger, Robert W. ;

Lowy, Douglas R. ;

Petersen, Lyle R. ;

Humes, Rosemary ;

Hepburn, Matthew ;

Cassetti, M. Cristina .

IMMUNITY, 2020, 53 (01) :1-5

← 1 2 3 →